From Florida Atlantic University Charles E. Schmidt College of Medicine (S.Z.S., K.A.S., K.M., N.B.E., G.A.M., B.M.S.), Boca Raton, Florida.
University of Miami Miller School of Medicine (S.S.S.), Miami, Florida.
AJNR Am J Neuroradiol. 2020 Mar;41(3):477-481. doi: 10.3174/ajnr.A6423. Epub 2020 Feb 20.
A shift has occurred in interventional cardiology from transfemoral to transradial access due to a 70%-80% decrease in complications. This shift has not yet taken place in other interventional specialties, perhaps owing to the lack of generalizability of findings in the cardiology data.
Our aim was to assess data from the recent mechanical thrombectomy prospective trials to better understand the access-site complication rate.
Articles were systematically sourced from the National Center for Biotechnology Information PubMed archive.
According to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines, prospective, randomized controlled trials published after 2008 with mention of major and/or minor femoral access-site complications in neuroendovascular mechanical thrombectomies were included.
Major and minor femoral access-site complications were extracted. A total complication rate was calculated with major access-site complications alone and combined with minor access-site complications.
Seven prospective studies of 339 total screened met the inclusion criteria. Eleven major access-site complications were identified in of 660 total interventions, revealing a major access-site complication rate of 1.67% for patients undergoing mechanical thrombectomy with transfemoral access. If minor access-site complications were included, 35 total incidents were detected in 763 interventions, resulting in a total complication rate of 4.59%.
Multiple unspecified vessel and procedure-related complications were mentioned in the studies.
The overall rate of major access-site complications was 1.67% in this review, which is not low and poses a risk to patients. We suggest further investigation into the feasibility and complication rates of alternative access sites for neurointerventional procedures.
由于并发症减少了 70%-80%,介入心脏病学已从股动脉入路转变为经桡动脉入路。这种转变尚未在其他介入专业中发生,可能是由于心血管数据中的发现缺乏普遍性。
我们旨在评估最近机械血栓切除术前瞻性试验的数据,以更好地了解入路部位并发症的发生率。
文章从国家生物技术信息中心 PubMed 档案系统进行系统检索。
根据系统评价和荟萃分析的首选报告项目,纳入了 2008 年后发表的、提及神经血管机械血栓切除术中大/小股动脉入路并发症的前瞻性、随机对照试验。
提取大/小股动脉入路并发症。仅计算主要入路并发症和主要与小入路并发症相结合的总并发症发生率。
7 项前瞻性研究共 339 例患者符合纳入标准。在 660 例总介入治疗中发现 11 例主要入路并发症,股动脉入路行机械血栓切除术的患者主要入路并发症发生率为 1.67%。如果包括小的入路并发症,在 763 例介入治疗中发现 35 例总事件,总并发症发生率为 4.59%。
研究中提到了多种未指定的血管和程序相关并发症。
本综述中主要入路并发症的总体发生率为 1.67%,这并不低,对患者构成风险。我们建议进一步研究神经介入手术替代入路的可行性和并发症发生率。